Mark Chin, Director, 10% Owner at Harpoon Therapeutics, Inc. (HARP), bought 2,149,269 shares at $14.00 ($6.0M) on 2019-02-12, disclosed to the SEC on 2019-02-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,720,698 | $0 | 0.0% |
| 2 | $14.00 | 428,571 | $6.0M | 100.0% |
| Total | $2.79 avg | 2,149,269 | $6.0M | 100% |
| Filing → |
| IMRA | BUY | 2021-07-28 | $8.0M | — | Filing → |
| IMRA | BUY | 2020-03-16 | $3.0M | — | Filing → |
| HARP | SELL | 2019-12-17 | $1.2M | — | Filing → |